Abstract:Alzheimer’s disease (AD) is a progressive neurological disorder characterized by brain cell death, brain atrophy, and cognitive decline. Early diagnosis of AD remains a significant challenge in effectively managing this debilitating disease. In this study, we aimed to harness the potential of single-cell transcriptomics data from 12 Alzheimer’s patients and 9 normal controls (NC) to develop a predictive model for identifying AD patients. The dataset comprised gene expression profiles of 33,538 genes across 169,469 cells, with 90,713 cells belonging to AD patients and 78,783 cells belonging to NC individuals. Employing machine learning and deep learning techniques, we developed prediction models. Initially, we performed data processing to identify genes expressed in most cells. These genes were then ranked based on their ability to classify AD and NC groups. Subsequently, two sets of genes, consisting of 35 and 100 genes, respectively, were used to develop machine learning-based models. Although these models demonstrated high performance on the training dataset, their performance on the validation/independent dataset was notably poor, indicating potential overoptimization. To address this challenge, we developed a deep learning method utilizing dropout regularization technique. Our deep learning approach achieved an AUC of 0.75 and 0.84 on the validation dataset using the sets of 35 and 100 genes, respectively. Furthermore, we conducted gene ontology enrichment analysis on the selected genes to elucidate their biological roles and gain insights into the underlying mechanisms of Alzheimer’s disease. While this study presents a prototype method for predicting AD using single-cell genomics data, it is important to note that the limited size of the dataset represents a major limitation. To facilitate the scientific community, we have created a website to provide with code and service. It is freely available at https://webs.iiitd.edu.in/raghava/alzscpred. Key Points Predictive Model for Alzheimer’s Disease Using Single Cell Transcriptomics Data Overoptimization of models trained on single-cell genomics data. Application of dropout regularization technique of ANN for reducing overoptimization Ranking of genes based on their ability to predict patients’ Alzheimer’s Disease Standalone software package for predicting Alzheimer’s Disease Author’s Biography Aman Srivastava is pursuing M. Tech. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India. Anjali Dhall is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India. Sumeet Patiyal is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India. Akanksha Arora is currently working as Ph.D. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India. Akanksha Jarwal is pursuing M. Tech. in Computational Biology from Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India. Gajendra P. S. Raghava is currently working as Professor and Head of Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.

Personalized Predictions from Population Level Experiments: A Study on Alzheimer's Disease

Time-to-event prediction using survival analysis methods for Alzheimer's disease progression

PREDICTING AMYLOID BURDEN TO ACCELERATE RECRUITMENT OF SECONDARY PREVENTION CLINICAL TRIALS

Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease

An Effective Approach for Predicting P-value using High-dimensional SNPs data with Small Sample Size

A Machine Learning Approach to Predict Cognitive Decline in Alzheimer's Disease Clinical Trials

Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments

Predicting Alzheimer's Disease with Interpretable Machine Learning.

High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer's Disease

Cognitive Biomarker Prioritization in Alzheimer's Disease using Brain Morphometric Data

Prediction of Alzheimer’s Disease from Single Cell Transcriptomics Using Deep Learning

A multimodal deep learning approach for the prediction of cognitive decline and its effectiveness in clinical trials for Alzheimer's disease

Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator

Predicting Counterfactuals from Large Historical Data and Small Randomized Trials

Synthetic data analysis for early detection of Alzheimer progression through machine learning algorithms

Prediction of cognitive decline for enrichment of Alzheimer's disease clinical trials

A non-parametric approach to predict the recruitment for randomized clinical trials: an example in elderly inpatient settings

Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework

Predicting how many people might receive treatment with new therapies for Alzheimers disease

Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data

Deep Recurrent Model for Individualized Prediction of Alzheimer's Disease Progression